openPR Logo
Press release

Keratoprosthesis Market to Rise at CAGR of 15.4% to Reach US$ 2.33 Billion by 2034: Fact.MR Study

03-19-2025 07:56 AM CET | Health & Medicine

Press release from: Fact.MR

Keratoprosthesis Market

Keratoprosthesis Market

The global market for keratoprosthesis is expected to reach US$ 553.5 million in 2024 and grow at a high-value CAGR of 15.4% through 2034, reaching US$ 2.33 billion.

The growth of the market is largely supported by the growing prevalence of eye disorders. Eye disorders like infectious keratitis, corneal stromal dystrophies, ocular cicatricial pemphigoid, and keratoconus are all contributing to a high demand for keratoprosthesis surgery. Studies show that the incidence of keratoconus is 50-200 per 100,000 individuals, and the United States has an incidence of 54.5 per 100,000 individuals. As the incidence of corneal diseases is increasing, the market for keratoprosthesis is anticipated to experience continued growth in the years to come.

For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=859

Segment-Wise Analysis

Biosynthetic Implants to Dominate the Keratoprosthesis Market

The keratoprosthesis market is classified by implant type into synthetic and biosynthetic implants. Biosynthetic implants are anticipated to have the largest market share, mainly because of their improved safety profile and reduced production costs. These factors render biosynthetic implants a favored option over conventional synthetic ones, and hence, they are expected to be in high demand throughout the forecast period.

Hospitals Leading in End-User Segment

The hospital segment is expected to hold 66% of the keratoprosthesis market share in 2024. The growing number of specialized eye clinics and the technical complexity of keratoprosthesis procedures render hospitals the preferred option for both patients and physicians. Hospitals offer access to trained professionals, precision surgical instruments, and transactional eye banks, leading to improved patient outcomes. These aspects are likely to contribute to long-term growth in the hospital segment during the forecast period.

Regional Analysis

Western Europe and North America to Drive Revenue Share

North America is expected to lead the keratoprosthesis market, followed by Western Europe. In Europe, Germany is a prominent market in view of growing healthcare investments and research activities. The United States' opt-out system for organ donation has greatly increased corneal donations, promoting market growth in the region.

Asia Pacific to Exhibit the Highest CAGR

Even though the Asia Pacific region at present is growth-constrained with a lack of skilled doctors, it is also anticipated to be the most profitable market with the highest CAGR. The rising use of keratoprosthesis surgeries and advances in healthcare infrastructure will drive market growth. China and India will soon become major contributors because of their immense population and increased spending on healthcare.

Middle East & Africa to Witness Moderate Growth

The Middle East and Africa are likely to realize steady yet slower growth because of limited technology growth and low adoption rates. Nevertheless, continued health care advancements in some regions of the area may aid in moderate market growth in the long run.

Browse Full Report: https://www.factmr.com/report/859/keratoprosthesis-market

New Advances in the Keratoprosthesis Market

New advances in keratoprosthesis concentrate on enhancing the integration of implants with host tissue, employing biocompatible material to maximize anatomical results. Researchers are stressing long-term survivability, but companies are confronting post-operative adverse events like glaucoma, extrusion, and infection. The creation of newer materials possessing better optical quality is a focal point of research.

In 2022, CorNeat Vision made the announcement that its CorNeat Kpro implant was undergoing clinical trials with a proposed market launch in 2024. More recently, collagen-based bioengineered corneas have seen increased support owing to their affordability and high compatibility in implantation, leading to safer and more effective surgical processes.

Major players in the keratoprosthesis market are investing heavily in new technologies and product development to establish a competitive advantage. The artificial cornea market is experiencing high competition, with leading players emphasizing product differentiation to meet the increasing demand for sophisticated keratoprosthesis products.

Segmentation of the Keratoprosthesis Market Research

By Implant Type :
Synthetic
Bio-Synthetic
Others
By Disease Indication :
Bullous Keratopathy
Keratoconus
Keratitis
Others
By End Users :
Hospitals
Ambulatory Surgical Centers
Others
By Region :
North America
Easter Europe
Western Europe
East Asia
Latin America
South Asia & Pacific
Eastern Europe
Middle East & Africa

Check out More Related Studies Published by Fact.MR:

Atherosclerosis Drugs Market
https://www.factmr.com/report/4434/atherosclerosis-drugs-market

Peptide-based Cancer Therapeutics Market
https://www.factmr.com/report/179/peptide-based-cancer-therapeutics-market

Gemcitabine HCl Market
https://www.factmr.com/report/4646/gemcitabine-hcl-market

Peptide Based Gastrointestinal Disorders Therapeutics Market
https://www.factmr.com/report/190/peptide-based-gastrointestinal-disorders-therapeutics-market

Contact:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

About Fact.MR

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Keratoprosthesis Market to Rise at CAGR of 15.4% to Reach US$ 2.33 Billion by 2034: Fact.MR Study here

News-ID: 3923469 • Views:

More Releases from Fact.MR

Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decoding
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Key Players: iRobot Corporation, Neato Robotics, Inc., Yujin Robot, Co., Ltd., and Dyson Inc
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke …
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleaners
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
08-29-2025 | Health & Medicine
Fact.MR
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offering
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2034 | Key Players: Johnson & Johnson Services Inc; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Takeda Pharmaceutical Company Limited
08-29-2025 | Health & Medicine
Fact.MR
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 …
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhance

All 5 Releases


More Releases for Keratoprosthesis

11-03-2022 | Health & Medicine
fact.mr
Global Keratoprosthesis Market Is Expected To Grow Continuously With A CAGR of 1 …
The keratoprosthesis market is expected to grow exponentially over the forecast period due to the increasing incidence of corneal infection. Increasing visual disability due to the cloudy cornea for working people has increased the demand for keratoprosthesis surgeries. Based on product types, the global keratoprosthesis market is segmented into Boston Keratoprosthesis, alphaCor, and others. Amongst them, Boston Keratoprosthesis is the most widely used treatment option for corneal disease. Read Report Overview: https://www.factmr.com/report/859/keratoprosthesis-market The
01-07-2022 | Health & Medicine
Fact.MR
Keratoprosthesis Market: Major Companies, Industry Analysis, Application, Region …
The New Report "Keratoprosthesis Market" published by Fact.MR, covers the competitive landscape analysis and its growth prospects over the coming years. An in-depth study of some new and prominent industry trends, analysis of engagement, and regional analysis that is very detailed have been included in the report of the Keratoprosthesis market for the analysis period of 2021 – 2031. Get In-depth Insights Request for Sample here: https://www.factmr.com/connectus/sample?flag=B&rep_id=859 Through the new research
08-03-2021 | Health & Medicine
Fact.MR
Keratoprosthesis Market to Witness Increase in Revenues during 2021-2031 | F. …
The Market Research Survey by “Fact.MR, A Market Research and Competitive Intelligence Provider” highlights the key reasons behind increasing demand of Keratoprosthesis. Keratoprosthesis market study depicts an in-depth analysis on the current status of Keratoprosthesis market that consists of important types, and end uses. To Get In-depth Information View the Report - https://www.factmr.com/report/859/keratoprosthesis-market Exponential rise in the use of medical devices on account of continued advances in design and superior operative care
07-14-2021 | Health & Medicine
Fact.MR
Keratoprosthesis Market Global Upcoming Demand, Growth Analysis and Forecast til …
The market report envelopes an all-in information of the global Keratoprosthesis market and the nature of the market growth over the foreseeable period. Keratoprosthesis Market to grow significantly during the years, 2021-2031. Amongst the product types, Boston Keratoprosthesis is the most widely used treatment. To Get In-depth Information View the Report - https://www.factmr.com/report/859/keratoprosthesis-market Rising geriatric population coupled with increasing incidence of eye diseases worldwide is expected to be the prime factor driving the
Keratoprosthesis Market by Key Players - F. Hoffmann-La Roche Ltd., Regeneron Ph …
Keratoprosthesis Market: Insights Exponential rise in the use of medical devices on account of continued advances in design and superior operative care has led to increase in the use of artificial cornea or keratoprosthesis in the recent years. The keratoprosthesis is intended to replace the damaged corneal tissue and restore vision of the patients with bilateral corneal disease. Corneal transplantation is one of the common treatment to correct several corneal opacity
12-20-2018 | Health & Medicine
Fact.MR
Global Keratoprosthesis Market Forecast Covering Growth Inclinations & Developme …
Exponential rise in the use of medical devices on account of continued advances in design and superior operative care has led to increase in the use of artificial cornea or keratoprosthesis in the recent years. The keratoprosthesis is intended to replace the damaged corneal tissue and restore vision of the patients with bilateral corneal disease. Corneal transplantation is one of the common treatment to correct several corneal opacity which involves